Abstract
Critical illness is associated with multiple system organ dysfunction, and neurologic dysfunction is increasingly assessed and recognized. Neurologic dysfunction includes encephalopathy, cognitive, neuromuscular and psychiatric impairments, all of which can be severe and are associated with significant morbidity. Medical technological advances have improved central nervous system monitoring in critically ill patients, allowing quick and reliable diagnosis neurologic dysfunction such as delirium, sensory processing deficits, seizures, and encephalopathy to name a few. A number of neurologic evaluation tools are available to assess the neurologic status of critically ill patients both acutely, as well as longterm. Each tool provides unique information regarding neurologic status and has associated strengths and weakness. Identification of neurologic dysfunction allows for the development of working plans for prognostication, therapeutics, and rehabilitation that address the needs of each ICU survivor. This review focuses on the evaluation of neurologic sequelae during critical illness and long-term neurologic outcomes in survivors of critical illness.
Keywords: Cognitive sequelae, neurologic dysfunction, depression, quality of life, critical illness, ICU
Current Respiratory Medicine Reviews
Title: Neurologic Sequelae in Critical Illness: Evaluation and Outcomes
Volume: 3 Issue: 4
Author(s): Mary R. Suchyta and Ramona O. Hopkins
Affiliation:
Keywords: Cognitive sequelae, neurologic dysfunction, depression, quality of life, critical illness, ICU
Abstract: Critical illness is associated with multiple system organ dysfunction, and neurologic dysfunction is increasingly assessed and recognized. Neurologic dysfunction includes encephalopathy, cognitive, neuromuscular and psychiatric impairments, all of which can be severe and are associated with significant morbidity. Medical technological advances have improved central nervous system monitoring in critically ill patients, allowing quick and reliable diagnosis neurologic dysfunction such as delirium, sensory processing deficits, seizures, and encephalopathy to name a few. A number of neurologic evaluation tools are available to assess the neurologic status of critically ill patients both acutely, as well as longterm. Each tool provides unique information regarding neurologic status and has associated strengths and weakness. Identification of neurologic dysfunction allows for the development of working plans for prognostication, therapeutics, and rehabilitation that address the needs of each ICU survivor. This review focuses on the evaluation of neurologic sequelae during critical illness and long-term neurologic outcomes in survivors of critical illness.
Export Options
About this article
Cite this article as:
Suchyta R. Mary and Hopkins O. Ramona, Neurologic Sequelae in Critical Illness: Evaluation and Outcomes, Current Respiratory Medicine Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/157339807782359904
DOI https://dx.doi.org/10.2174/157339807782359904 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Chronic obstructive pulmonary disease (COPD) from childhood to adulthood: from the past to the future
Chronic obstructive pulmonary disease (COPD) is one of the three leading causes of death worldwide, with a major prevalence in low- and middle-income countries, resulting in a high social and economic cost. It is a heterogeneous respiratory disease, treatable and preventable, that causes persistent and often progressive airway obstruction in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anti-leishmanial Activity of Gossypium hirsutum L., Ferula assa-foetida L. and Artemisia aucheri Boiss. Extracts by Colorimetric Assay
Anti-Infective Agents CYP-Mediated Clozapine Interactions: How Predictable Are They?
Current Drug Metabolism HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles
Current Cancer Drug Targets Melatonin, a Potential Therapeutic Agent for Smooth Muscle-Related Pathological Conditions and Aging
Current Medicinal Chemistry Systematic Review on Infusion Reactions Associated with Chemotherapies and Monoclonal Antibodies for Metastatic Colorectal Cancer
Current Clinical Pharmacology The Endocannabinoid System in Ageing: A New Target for Drug Development
Current Drug Targets Lemont B. Kier: A Bibliometric Exploration of his Scientific Production and its Use
Current Computer-Aided Drug Design Treatment of Inflammatory and Paraproteinemic Neuropathies
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Advances in Biologic Agents for the Treatment of Rheumatoid Arthritis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors
Current Pharmaceutical Design Autonomic Nervous System in Viral Myocarditis: Pathophysiology and Therapy
Current Pharmaceutical Design Noradrenergic System in Down Syndrome and Alzheimer’s Disease A Target for Therapy
Current Alzheimer Research New Developments in Therapeutic Agents for Legionnaires Disease
Anti-Infective Agents in Medicinal Chemistry Rho Kinase Inhibitors and Novel Ocular Drug Delivery Systems- A Revolutionary Step Towards the Treatment of Glaucoma
Current Drug Delivery Monoclonal Antibodies in the Treatment of Leukemia
Current Molecular Medicine Glucocorticoids Involvement in the Control of CNS Excitability
Recent Patents on CNS Drug Discovery (Discontinued) 2,5-Diketopiperazines: A Review of Source, Synthesis, Bioactivity, Structure, and MS Fragmentation
Current Medicinal Chemistry Cardiovascular Effects of Coumarins Besides their Antioxidant Activity
Current Topics in Medicinal Chemistry Zolpidem Arousing Effect in Persistent Vegetative State Patients: Autonomic, EEG and Behavioral Assessment
Current Pharmaceutical Design Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson's Disease
CNS & Neurological Disorders - Drug Targets